Myles Cabot, Ph.D.

John Wayne Cancer Institute
email: none

Grants

Nongenomic actions of antiestrogens 1996 (Cycle II)
Research Project Awards 2RB-0211 $495,150


Glucosylceramide: a marker for multiple-drug resistant cancers
  Periodical: Anticancer Research
  Author(s): Lucci A, Cho WI, Han TY, Giuliano AE, Morton DL, Cabot MC
  Yr: 1998 Vol: 18 Nbr: 1B Pgs: 475-80
  Associated Grant: Nongenomic actions of antiestrogens
 
Tamoxifen induces selective membrane association of protein kinase C epsilon in MCF-7 human breast cancer cells.
  Periodical: International Journal of Cancer
  Author(s): Lavie Y, Zhang ZC, Cao HT, Han TY, Jones RC, Liu YY, Jarman M, Hardcastle IR, et al.
  Yr: 1998 Vol: 77 Nbr: 6 Pgs: 928-932
  Associated Grant: Nongenomic actions of antiestrogens
 
Apoptosis - A cell mechanism important for cytotoxic response to adriamycin and a lipid metabolic pathway that facilitates escape
  Periodical: Breast Cancer Research and Treatment
  Author(s): Cabot MC, and Giuliano AE
  Yr: 1997 Vol: 46 Nbr: 1 Pgs: 71
  Associated Grant: Nongenomic actions of antiestrogens
 
Tamoxifen activates cellular phospholipase C and D and elicits protein kinase C translocation
  Periodical: International Journal of Cancer
  Author(s): Cabot MC, Zhang ZC, Cao HT, et al
  Yr: 1997 Vol: 70 Nbr: Pgs: 567-574
  Associated Grant: Nongenomic actions of antiestrogens
 
Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycoslation in human cancer cells
  Periodical: Journal of Biological Chemistry
  Author(s): Lavie Y, Cao HT, Volner A, et al
  Yr: 1997 Vol: 272 Nbr: 3 Pgs: 1682-1687
  Associated Grant: Nongenomic actions of antiestrogens
 
Altering glycolipid metabolism in MDR cells, new ideas in cancer treatment
  Periodical: Proceedings of the American Association for Cancer Research
  Author(s): Jones RC, Cho WI, Han TY, Jarman M, Hardcastle IR, Cabot MC
  Yr: 1997 Vol: 398 Nbr: Pgs: 593
  Associated Grant: Nongenomic actions of antiestrogens
 
Tamoxifen retards glycosphingolipid metabolism in human cancer cells
  Periodical: FEBS Journal
  Author(s): Cabot MC, Guiliano AE, Volner A, Han TY
  Yr: 1996 Vol: 394 Nbr: Pgs:
  Associated Grant: Nongenomic actions of antiestrogens
 
Role of glycolipids in reversing adriamycin resistance in breast cancer -- new targets for drug design
  Periodical: American Association for Cancer Research Basic and Clinical Aspects of Breast Cancer
  Author(s): Cabot MC, Jones RC, Cho WI, Lucci A, Giulianon AE, Han TY
  Yr: 0 Vol: Nbr: Pgs:
  Associated Grant: Nongenomic actions of antiestrogens